Jump to content


Friday's Chat times: 4pm UK/ 10am USA Eastern time / 8am USA Pacific time/9am USA Mountain time/10am USA Central time and Saturday at 6am in Melbourne, Australia. Do visit the Chat Room and join us!!

MEDICAL NEWS

New evidence on how weight, diet and exercise can help reduce cancer risk. Common-sense lifestyle strategies for lowering the risk of heart disease and diabetes are now being shown to help prevent many types of cancer. Washington Post, 02/18/2014. (Also see:Cancer and Scleroderma)

Hemostatic and Fibrinolytic Changes Are Related to Inflammatory Conditions in Patients with Psoriatic Arthritis (PsA) — Effect of Different Treatments. Tumor necrosis factor (TNF)-α inhibitors brought about a significant improvement of hemostatic and fibrinolytic balance in subjects with PsA. Maximal changes were found in patients achieving minimal disease activity (MDA.) PubMed, J Rheumatol. 2014 Feb 15. (Also see: Treatments for Psoriatic Arthritis)

Early systemic sclerosis (SSc): Analysis of the disease course in patients with marker autoantibody or capillaroscopic positivity or both. The data demonstrate faster progression of SSc in autoantibody–positive patients, particularly in those with preclinical internal organ involvement at baseline, than in autoantibody–negative patients. PubMed, Arthritis Care Res (Hoboken), 2014 Feb 10. (Also see: Scleroderma Autoantibodies and Capillaroscopy)

New therapies raise hope for a breakthrough in tackling cancer. Immune-checkpoint blockade is a form of immunotherapy, meaning it aims to help the patient's own immune system fight cancer. Washington Post, 02/18/2014. (Also see: Cancer and Scleroderma)

Incidence of lymphoma associated with underlying lupus (SLE): Lessons learned from observational studies. Although the association of non-Hodgkin's lymphoma in SLE is well established, risk factors attributing to this association are still not understood. PubMed, Curr Opin Rheumatol. 2014 Mar;26(2):111-7. (Also see: Systemic Lupus Erythematosus Symptoms and Non Hodgkin's Lymphoma)

Patients with Systemic Sclerosis (SSc) Present Increased DNA Damage Differentially Associated with DNA Repair Gene Polymorphisms. Polymorphic sites of the XRCC1 and XRCC4 DNA repair genes may differentially influence DNA damage and the development of autoantibodies. PubMed, J Rheumatol, 2014 Feb 1. (Also see: Causes of Scleroderma: Genetics)

Loneliness and feeling unloved TWICE as likely to kill you as being fat... as scientists warn against elderly retiring to sunnier climes. Being lonely in later life could be worse for your health than obesity, according to research. Mail Online, 02/16/2014.

T cell repertoire (TCR) following autologous stem cell transplantation for multiple sclerosis. TCR characterization during immunomodulatory treatment is both feasible and informative, and may enable monitoring of pathogenic or protective T cell clones following HSCT and cellular therapies. PubMed, J Clin Invest. 2014 Feb 17. (Also see: Multiple Sclerosis and Stem Cell Transplantation)

Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in CTD-ILD Efforts described here demonstrate unequivocally the value and influence of patient involvement on core set development. PubMed, J Rheumatol, 2014 Feb 1. (Also see: Pulmonary Fibrosis and Connective Tissue Disease)

Forgotten your keys? Memory loss as you age is entirely normal, scientists conclude… and they even say a 'cure' is in sight. Forgetting where you put your keys or someone's name is a perfectly normal part of the aging process and well underway by the age of 40, scientists have said. Mail Online, 02/15/2014.

Gender differences in multiple sclerosis (MS): induction of estrogen signaling in male and progesterone signaling in female lesions. The different gender–specific responses in steroid synthesis and signaling in the brains of multiple sclerosis (MS) patients may represent contributing factors to gender differences in the prevalence and course of MS. PubMed, J Neuropathol Exp Neurol. 2014 Feb;73(2):123-35. (Also see: Multiple Sclerosis)

Disease progression in systemic sclerosis (SSc)-overlap syndrome is significantly different from limited (IcSSc) and diffuse cutaneous systemic sclerosis (dcSSc). SSc-overlap syndromes should be regarded as a separate SSc subset, distinct from lcSSc and dcSSc, due to a different progression of the disease, different proportional distribution of specific autoantibodies, and of different organ involvement. PubMed, Ann Rheum Dis, 2014 Jan 3. (Also see: Systemic Scleroderma in Overlap)

Sclero Forums (MAIN)

Serving everyone in the world who is interested in scleroderma or related illnesses, such as Raynaud's and Pulmonary Hypertension. (Please use English only.)

  • Please log in to post a topic
  Topic Started By Stats Last Post Info

  • Please log in to post a topic